Academic Articles & Research Papers

Nursing interventions for managing treatment-related adverse effects of targeted anti-tumor therapies in adult cancer patients: a scoping review.

Alqaisi O, Al-Ghabeesh S, Dibas M, Alwaqfi Y et al. • Frontiers in pharmacology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fphar.2026.1936674 PMC: PMC13727521

View Article » Original Source ↗

Anti-bladder cancer effects of nuciferine, a bioactive compound extracted from Nelumbo nucifera leaves.

Qin B, Liang H, Kuang T, Wei C et al. • Frontiers in nutrition (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fnut.2026.1881388 PMC: PMC13727535

View Article » Original Source ↗

From epidemiology to molecular pathology: current research status and future prospects on the role of toxic metal exposure in the development and progression of bladder cancer.

Li D, Sun X, Yu T • Frontiers in cell and developmental biology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fcell.2026.1930640 PMC: PMC13728351

View Article » Original Source ↗

Discordance of PD-L1 expression between primary and paired metastatic non-small cell lung cancer: a systematic review and meta-analysis.

Zhang L, Gao Y, Wang X, Gu Y et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1942041 PMC: PMC13728784

View Article » Original Source ↗

Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy.

Kurmanalina G, Medovchshikov V, Valanik S, Aringazina R • Frontiers in oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fonc.2026.2001431 PMC: PMC13728875

View Article » Original Source ↗

The evolution of antigen specific cancer immunotherapy from adoptive cell therapy to personalized cancer vaccines.

Chen Q, Yang S, Yu H, He Y et al. • Discover oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s12672-026-05719-1 PMC: PMC13727929

View Article » Original Source ↗

paRDal: bioinformatics framework for a parallel RNA and DNA NGS analysis in hereditary cancer diagnostics.

Matejkova K, Nehasil P, Kleiblova P, Ptackova T et al. • Frontiers in bioinformatics (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fbinf.2026.1944540 PMC: PMC13728347

View Article » Original Source ↗

ZNF114 as a prognostic biomarker associated with Wnt/EMT and immune-related features in gastric cancer.

Li W, Zhang Z, Li Y, Xing A et al. • Frontiers in oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fonc.2026.1946670 PMC: PMC13728929

View Article » Original Source ↗

JAK-STAT signaling: a key mechanism of immune microenvironment remodeling in breast cancer and novel strategies for targeted therapy.

Qiao J, Sun T, Wang G, Yan Y et al. • Frontiers in oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fonc.2026.1947188 PMC: PMC13728782

View Article » Original Source ↗

Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years Due to Cancer Among Adolescents Aged 10-19 Years in Iran, 1990-2023: A Trend Analysis of the Global Burden of Disease Study.

Azarbakhsh H, Hamedi A, Amiri S, Dehghani SP et al. • Health science reports (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/hsr2.73397 PMC: PMC13729004

View Article » Original Source ↗

A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer.

Wu J, Ji R, Wang L, Zhu Y et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.07.045 PMC: PMC13730232

View Article » Original Source ↗

Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation.

Chen S, Wang X, Xuan Q, Liu C et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.08.007 PMC: PMC13730233

View Article » Original Source ↗

A novel peptide-drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis.

Yu L, He Y, Liu G, Wei Q et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.06.055 PMC: PMC13729533

View Article » Original Source ↗

TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway.

Yang L, Zhan M, Yang R, Guo M et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.08.019 PMC: PMC13729714

View Article » Original Source ↗

Portulaca oleracea L.-derived extracellular vesicle-like particles reprogram intestinal ILCs to alleviate inflammatory bowel disease and colitis-associated colorectal cancer.

Zhong H, Liu Z, Zhao Z, Yao S et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.07.044 PMC: PMC13730234

View Article » Original Source ↗

Incorporating natural language processing-derived features from pathology reports into machine learning models to predict differentiated thyroid cancer recurrence.

Lee DT, Yen S, Deng G, Elkersh Y et al. • Frontiers in endocrinology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fendo.2026.1939077 PMC: PMC13730829

View Article » Original Source ↗

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients.

Werner S, Tennstedt P, Pose RC, Müller C et al. • Molecular oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/1878-0261.70244 PMC: PMC13398947

View Article » Original Source ↗

The role of patient age in fertility preservation among women with breast cancer: biological mechanisms and clinical implications.

Placidi M, Ludovisi M, Pizzorno L, Sidoni T et al. • Journal of assisted reproduction and genetics (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s10815-026-03923-0 PMC: PMC13731550

View Article » Original Source ↗

Unsupervised clustering FLIM-phasor from multifunctionalized nanoparticles in living cancer cells.

Flores DL, Guerra-Rosas E, Benítez-Mata B, Hirata G et al. • Methods and applications in fluorescence (2026)

PMC PMC Public Access (View-Only) DOI: 10.1088/2050-6120/ae7fed PMC: PMC13733409

View Article » Original Source ↗

Successful palliative hypofractionated radiotherapy with superficial hyperthermia for heavily pretreated cutaneous breast cancer lesions.

de Vries-Huizing DMV, Holtmaat A, Kolff MW, Crezee J • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s00066-026-02536-x PMC: PMC13731711

View Article » Original Source ↗